Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(12 sites)

Belgium

CHU de Liège, Liège, Liège

UZ Gent, Ghent, Oost-Vlaanderen

UZ Leuven, Leuven, Vlaams-Brabant

France

Institut De Cancerologie Strasbourg Europe, Strasbourg, Bas-Rhin

Institut Bergonie, Bordeaux, Gironde

Institut Universitaire Du Cancer Toulouse-Oncopole, Toulouse, Haute-Garonne

Institut De Cancerologie De L'Ouest, Saint-Herblain, Loire-Atlantique

Centre Leon Berard, Lyon, Métropole de Lyon

Groupe Hospitalier Diaconesses Croix Saint Simon, Paris, Île-de-France Region

Netherlands

University Medical Center Groningen, Groningen, Provincie Groningen

Erasmus Medical Center Rotterdam, Rotterdam, South Holland

University Medical Center Utrecht, Utrecht, Utrecht